Acutus Stock Analysis

AFIB -  USA Stock  

USD 2.45  0.08  3.16%

The big decline in price over the last few months for Acutus Medical could raise concerns from investors as the firm it trading at a share price of 2.45 on 151,445 in volume. The company executives failed to add value to investors and positioning the firm supply of money to exploit market volatility in December. However, diversifying your holdings with Acutus Medical or any similar stocks can still protect your portfolios during high-volatility market scenarios. The stock standard deviation of daily returns for 90 days investing horizon is currently 7.86. The very high volatility is mostly attributed to the latest market swings and not very good earnings reports from some of the Acutus Medical partners.
Please continue to Trending Equities.

Acutus Stock Analysis 

The Acutus Medical stock analysis report makes it easy to digest most publicly released information about Acutus Medical and get updates on important government artifacts, including earning estimates, SEC corporate filings, and announcements. Acutus Stock analysis module also helps to analyze the Acutus Medical price relationship with some important fundamental indicators such as market cap and management efficiency.

Acutus Stock Analysis Notes

About 79.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 0.56. Some equities with similar Price to Book (P/B) outperform the market in the long run. Acutus Medical recorded a loss per share of 4.04. The entity had not issued any dividends in recent years. Acutus Medical, Inc., an arrhythmia management company, designs, manufactures, and markets a range of tools for catheter-based ablation procedures to treat various arrhythmias in the United States and internationally. Acutus Medical, Inc. was incorporated in 2011 and is based in Carlsbad, California. Acutus Medical operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 291 people. For more info on Acutus Medical please contact the company at 442 232 6080 or go to

Acutus Medical Quarterly Cost of Revenue

8.54 MillionShare

Acutus Medical Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Acutus Medical's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Acutus Medical or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Acutus Medical generated a negative expected return over the last 90 days
Acutus Medical has high historical volatility and very poor performance
Acutus Medical has high likelihood to experience some financial distress in the next 2 years
The company reported the previous year's revenue of 15.47 M. Net Loss for the year was (115.82 M) with loss before overhead, payroll, taxes, and interest of (7.42 M).
Acutus Medical currently holds about 130.45 M in cash with (101.23 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.67, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Acutus Medical has a frail financial position based on the latest SEC disclosures
Over 79.0% of the company shares are held by institutions such as insurance companies
Latest headline from Health Care Sector Update for 01142022 GLS,PRTC,BBLN,CRVS,AFIB - Nasdaq

Acutus Medical Upcoming and Recent Events

Earnings reports are used by Acutus Medical to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Acutus Medical previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
Upcoming Quarterly Report17th of March 2022
Next Earnings Report11th of May 2022
Next Fiscal Quarter End31st of December 2021
Next Fiscal Year End17th of March 2022
Last Quarter Report30th of September 2021
Last Earning Announcement31st of December 2020

Acutus Largest EPS Surprises

Earnings surprises can significantly impact Acutus Medical's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Fiscal Date
Estimated EPS
Reported EPS
View All Earnings Estimates

Acutus Medical SEC Filings

SEC filings are important regulatory documents required of all public companies to provide to potential investors. Acutus Medical prospectus issued under the guidelines of SEC is a legal declaration of facts and statements to ensure that Acutus Medical investors are not misled. SEC filings are required by law to meet strict transparency standards and other important legal constraints. Although many companies may choose careful wording to disguise some material information, SEC filings make crucial Acutus Medical specific information freely available to individual and institutional investors to make a timely investment decision.
18th of November 2021
Unclassified Corporate Event
12th of November 2021
Financial Statements and Exhibits. Results of Operations and Financial Condition
31st of August 2021
Unclassified Corporate Event
26th of August 2021
Unclassified Corporate Event
23rd of August 2021
Financial Statements and Exhibits. Unregistered Sales of Equity Securities. Entry into a Material Definitive Agreement
12th of August 2021
Regulation FD Disclosure. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Results of Operations and Financial Condition
21st of July 2021
Unclassified Corporate Event. Unclassified Corporate Event
13th of July 2021
Unclassified Corporate Event

Acutus Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Acutus Medical is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Acutus Medical backward and forwards among themselves. Acutus Medical's institutional investor refers to the entity that pools money to purchase Acutus Medical's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Security TypeSharesValue
Sa Mason LlcCommon Shares8.1 K28 K
Tarbox Family Office IncCommon Shares3421000
Deerfield Management Company Lp Series CCommon Shares2.6 M23.4 M
Orbimed Advisors LlcCommon Shares2.6 M23.4 M
Capital World InvestorsCommon Shares1.6 M14.1 M
Millennium Management LlcCommon Shares1.4 M12.2 M
Kerrisdale Advisers LlcCommon Shares1.3 M11.7 M
Note, although Acutus Medical's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Acutus Market Capitalization

The company currently falls under 'Micro-Cap' category with current market capitalization of 74.35 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Acutus Medical's market, we take the total number of its shares issued and multiply it by Acutus Medical's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities.

Acutus Profitablity

Acutus Medical's profitability indicators refer to fundamental financial ratios that showcase Acutus Medical's ability to generate income relative to its revenue or operating costs. If, let's say, Acutus Medical is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Acutus Medical's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Acutus Medical's profitability requires more research than a typical breakdown of Acutus Medical's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
Last ReportedProjected for 2022
Return on Average Assets(0.83) (0.89) 
Return on Average Equity 2.07  1.77 
Return on Invested Capital(1.01) (1.09) 
Return on Sales(13.11) (14.14) 

Management Efficiency

The entity has return on total asset (ROA) of (34.16) % which means that it has lost $34.16 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (80.9) %, meaning that it created substantial loss on money invested by shareholders. Acutus Medical management efficiency ratios could be used to measure how well acutus medical manages its routine affairs as well as how well it operates its assets and liabilities. As of January 19, 2022, Return on Average Assets is expected to decline to -0.89. In addition to that, Return on Average Equity is expected to decline to 1.77. Acutus Medical Goodwill and Intangible Assets are projected to increase significantly based on the last few years of reporting. The past year's Goodwill and Intangible Assets were at 20.33 Million. The current year Tangible Assets Book Value per Share is expected to grow to 14.16, whereas Total Assets are forecasted to decline to about 179 M.
Last ReportedProjected for 2022
Book Value per Share 12.76  13.77 
Enterprise Value over EBIT(7.20) (7.77) 
Enterprise Value over EBITDA(7.63) (8.23) 
Price to Book Value 5.70  5.67 
Tangible Assets Book Value per Share 13.80  14.16 
Enterprise Value706.3 M702.2 M
Tangible Asset Value201.1 M161.8 M

Technical Drivers

As of the 19th of January, Acutus Medical shows the mean deviation of 4.78, and Risk Adjusted Performance of (0.15). Acutus Medical technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We were able to collect and analyze data for nineteen technical drivers for Acutus Medical, which can be compared to its rivals. Please confirm Acutus Medical jensen alpha, potential upside, skewness, as well as the relationship between the maximum drawdown and semi variance to decide if Acutus Medical is priced correctly, providing market reflects its regular price of 2.45 per share. Please also double-check Acutus Medical total risk alpha, which is currently at (1.61) to validate the company can sustain itself at a future point.

Acutus Medical Price Movement Analysis

Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Mid-point over period is an average of Acutus Medical highest and lowest values attained during the given period. View also all equity analysis or get more info about midpoint over period overlap studies indicator.

Acutus Medical Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Acutus Medical insiders, such as employees or executives, is commonly permitted as long as it does not rely on Acutus Medical's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Acutus Medical insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Acutus Medical Predictive Daily Indicators

Acutus Medical intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Acutus Medical stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Acutus Medical Forecast Models

Acutus Medical time-series forecasting models is one of many Acutus Medical's stock analysis techniquest aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Acutus Medical's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

About Acutus Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Acutus Medical stock is reacting to, or reflecting on a current stock market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Acutus shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas, a specific sector, or an individual stock such as Acutus Medical. By using and applying Acutus Stock analysis, traders can create a robust methodology for identifying Acutus entry and exit points for their positions.
Last ReportedProjected for 2022
EBITDA Margin(12.57) (13.56) 
Gross Margin(1.01) (1.09) 
Profit Margin(13.86) (14.95) 
Acutus Medical, Inc., an arrhythmia management company, designs, manufactures, and markets a range of tools for catheter-based ablation procedures to treat various arrhythmias in the United States and internationally. Acutus Medical, Inc. was incorporated in 2011 and is based in Carlsbad, California. Acutus Medical operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 291 people.

Current Acutus Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Acutus analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Acutus analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
Acutus Medical current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Acutus analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Acutus stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Acutus Medical, talking to its executives and customers, or listening to Acutus conference calls.
Acutus Analyst Advice Details

Acutus Stock Analysis Indicators

Acutus Medical stock analysis indicators help investors evaluate how Acutus Medical stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Acutus Medical shares will generate the highest return on investment. By understating and applying Acutus Medical stock analysis, traders can identify Acutus Medical position entry and exit signals to maximize returns.
Quick Ratio7.44
Fifty Two Week Low2.5100
Revenue Growth45.00%
Shares Short Prior Month1.16M
Average Daily Volume Last 10 Day416.21k
Average Daily Volume In Three Month506.07k
Shares Percent Shares Out2.40%
Gross Margins-80.14%
Short Percent Of Float6.15%
Forward Price Earnings-0.83
Float Shares18.47M
Fifty Two Week High29.9500
Enterprise Value To Ebitda-0.13
Fifty Day Average3.8732
Two Hundred Day Average10.7122
Enterprise Value To Revenue0.89
Please continue to Trending Equities. Note that the Acutus Medical information on this page should be used as a complementary analysis to other Acutus Medical's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.

Complementary Tools for Acutus Stock analysis

When running Acutus Medical price analysis, check to measure Acutus Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Acutus Medical is operating at the current time. Most of Acutus Medical's value examination focuses on studying past and present price action to predict the probability of Acutus Medical's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Acutus Medical's price. Additionally, you may evaluate how the addition of Acutus Medical to your portfolios can decrease your overall portfolio volatility.
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Price Transformation
Use Price Transformation models to analyze depth of different equity instruments across global markets
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Is Acutus Medical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Acutus Medical. If investors know Acutus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Acutus Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Acutus Medical is measured differently than its book value, which is the value of Acutus that is recorded on the company's balance sheet. Investors also form their own opinion of Acutus Medical's value that differs from its market value or its book value, called intrinsic value, which is Acutus Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Acutus Medical's market value can be influenced by many factors that don't directly affect Acutus Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Acutus Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine Acutus Medical value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Acutus Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.